GC
Guggenheim Capital Portfolio holdings
AUM
$12.3B
1-Year Return
20.77%
This Quarter Return
+7.55%
1 Year Return
+20.77%
3 Year Return
+81.12%
5 Year Return
+133.86%
10 Year Return
+300.64%
AUM
$13.7B
AUM Growth
+$884M
(+6.9%)
Cap. Flow
+$97.2M
Cap. Flow
% of AUM
0.71%
Top 10 Holdings %
Top 10 Hldgs %
25.75%
Holding
1,984
New
118
Increased
754
Reduced
1,012
Closed
75
Top Buys
Top Sells
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$151M |
| 2 |
iShares Silver Trust
SLV
|
+$60.8M |
| 3 |
Apple
AAPL
|
+$32.3M |
| 4 |
GBAB
Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust
GBAB
|
+$21.3M |
| 5 |
Freeport-McMoran
FCX
|
+$18.6M |
Sector Composition
| 1 | Technology | 17.03% |
| 2 | Financials | 10.93% |
| 3 | Healthcare | 8.92% |
| 4 | Consumer Discretionary | 8.34% |
| 5 | Communication Services | 5.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Kulicke & Soffa
KLIC
$1.98B
| $325K | ﹤0.01% |
+14,527
| New | +$325K |
|
|
BCPC
1602
Balchem Corporation
BCPC
$5.05B
| $325K | ﹤0.01% |
3,328
+943
| +40% | +$92.1K |
|
1603
The Greenbrier Companies
GBX
$1.42B
| $325K | ﹤0.01% |
+11,069
| New | +$325K |
|
1604
MillerKnoll
MLKN
$1.38B
| $324K | ﹤0.01% |
10,759
-2,939
| -21% | -$88.5K |
|
1605
Valvoline
VVV
$5B
| $324K | ﹤0.01% |
17,026
+3,884
| +30% | +$73.9K |
|
1606
Delek US
DK
$1.79B
| $323K | ﹤0.01% |
29,009
-3,489
| -11% | -$38.8K |
|
1607
iShares Preferred and Income Securities ETF
PFF
$14.6B
| $323K | ﹤0.01% |
+8,848
| New | +$323K |
|
1608
Hanmi Financial
HAFC
$754M
| $321K | ﹤0.01% |
39,110
| – | – |
|
1609
MACOM Technology Solutions
MTSI
$9.81B
| $321K | ﹤0.01% |
9,451
-188,138
| -95% | -$6.39M |
|
1610
Heron Therapeutics
HRTX
$195M
| $320K | ﹤0.01% |
+21,564
| New | +$320K |
|
1611
Prestige Consumer Healthcare
PBH
$3.2B
| $319K | ﹤0.01% |
+8,750
| New | +$319K |
|
|
PCN
1612
PIMCO Corporate & Income Strategy Fund
PCN
$851M
| $318K | ﹤0.01% |
20,365
-567
| -3% | -$8.85K |
|
|
GF
1613
New Germany Fund
GF
$185M
| $317K | ﹤0.01% |
18,779
+6,432
| +52% | +$109K |
|
1614
Innospec
IOSP
$2.06B
| $316K | ﹤0.01% |
4,983
+170
| +4% | +$10.8K |
|
|
DEA
1615
Easterly Government Properties
DEA
$1.06B
| $315K | ﹤0.01% |
5,633
-1,264
| -18% | -$70.7K |
|
1616
Allegiant Air
ALGT
$1.16B
| $314K | ﹤0.01% |
2,619
+496
| +23% | +$59.5K |
|
1617
Under Armour Class C
UA
$2.09B
| $314K | ﹤0.01% |
31,886
-2,202
| -6% | -$21.7K |
|
|
GRX
1618
Gabelli Healthcare & Wellness Trust
GRX
$144M
| $313K | ﹤0.01% |
30,303
+13,380
| +79% | +$138K |
|
|
NEWR
1619
DELISTED
New Relic, Inc.
NEWR
| $311K | ﹤0.01% |
5,521
+1,640
| +42% | +$92.4K |
|
1620
Resideo Technologies
REZI
$5.39B
| $309K | ﹤0.01% |
28,100
+14,467
| +106% | +$159K |
|
1621
ArcBest
ARCB
$1.61B
| $307K | ﹤0.01% |
+9,882
| New | +$307K |
|
1622
Plains GP Holdings
PAGP
$3.67B
| $307K | ﹤0.01% |
50,382
-7,739
| -13% | -$47.2K |
|
|
EGF
1623
DELISTED
Blackrock Enhanced Government Fund, Inc.
EGF
| $306K | ﹤0.01% |
+22,841
| New | +$306K |
|
|
MDP
1624
DELISTED
Meredith Corporation
MDP
| $306K | ﹤0.01% |
23,310
-5,235
| -18% | -$68.7K |
|
1625
Amicus Therapeutics
FOLD
$2.45B
| $305K | ﹤0.01% |
+21,572
| New | +$305K |
|